CombiScreen – SYS PLUS urine test strips

Beschreibung

Beschreibung

CombiScreen SYS PLUS urine test strips are in-vitro diagnostics for advanced urinalysis with the simultaneous determination of multiple parameters. Designed for automated, instrument-based analysis, these test strips support standardized measurements in professional settings. Analysis is performed in a single step and is optimized for reproducible results within routine clinical practice. Specific test fields for blood and glucose are ascorbic acid-free to largely reduce interference from vitamin C.

Application areas

These urine test strips are suitable for rapid urine analysis in doctors‘ offices, clinics, and laboratories. They can be used in routine diagnostics as well as for monitoring disease progression when automated urine analysis with compatible evaluation devices is planned. Their application is within the framework of professional in-vitro diagnostics.

Advantages at a glance

The test strips enable the simultaneous analysis of 11 urine parameters, thus supporting efficient workflows in routine practice. Ascorbic acid-shielded test pads for blood and glucose are designed to virtually eliminate interference from vitamin C and improve the quality of results. Instrumental analysis allows for clear and reproducible measurement results, provided sample handling, instrument configuration, and quality controls comply with the respective specifications. The product is designed for professional use.

Further information

CombiScreen SYS PLUS urine test strips are intended exclusively for professional in-vitro diagnostic use and are not for self-testing. They are designed for use with the Urilyzer 100 and Urilyzer 500 Pro urine analyzers. Procedures for testing, evaluation, storage, and internal quality controls must be followed in accordance with the manufacturer’s instructions and the device specifications. Results must be interpreted within the clinical context; in the case of abnormal or implausible findings, appropriate confirmatory or follow-up investigations should be considered.